Back to SEI INVESTMENTS CO SEI INVESTMENTS CO

AKROAKRO
13 quarters

Position history for SEI INVESTMENTS COSEI INVESTMENTS CO's holdings in AKERO THERAPEUTICS INC

As of its Q3 2025 13F, SEI Investments held 17,131 shares of AKRO (Akero Therapeutics), worth $813,336. SEI Investments' 13F filings listed AKRO from Q4 2024 to Q3 2025, 4 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$399,000

Total Shares Change

-12,969

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$47.62
0
2025-Q3
Increased
17,131
+47.7%
$813,3360.0%$47.62
34
2025-Q2
Decreased
11,602
-30.9%
$619,0600.0%$56.19
0
2025-Q1
Increased
16,779
+54.1%
$679,2640.0%$42.72
35
2024-Q4
New
10,887
-
$302,8860.0%$27.96
32
2023-Q4
Exited
0
-100.0%
$00.0%$23.35
0
2023-Q3
Increased
18,908
+38.8%
$956,3670.0%$50.58
33
2023-Q2
Increased
13,624
+17.4%
$636,1060.0%$44.64
29
2023-Q1
Decreased
11,600
-24.1%
$443,8150.0%$37.80
0
2022-Q4
Decreased
15,278
-4.2%
$837,2360.0%$54.80
0
2022-Q3
New
15,951
-
$543,0000.0%$29.80
34
2020-Q4
Exited
0
-100.0%
$00.0%$26.11
0
2020-Q3
New
12,969
-
$399,0000.0%$31.37
33

Other major holders of AKRO: Janus Henderson Group Ltd., BlackRock, Inc., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used